Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model.

Luchtel RA, Bhagat T, Pradhan K, Jacobs WR Jr, Levine M, Verma A, Shenoy N.

Proc Natl Acad Sci U S A. 2020 Jan 21;117(3):1666-1677. doi: 10.1073/pnas.1908158117. Epub 2020 Jan 7.

2.

Comparison of Transcutaneous Electric Nerve Stimulation (TENS) and Microcurrent Nerve Stimulation (MENS) in the Management of Masticatory Muscle Pain: A Comparative Study.

Saranya B, Ahmed J, Shenoy N, Ongole R, Sujir N, Natarajan S.

Pain Res Manag. 2019 Nov 23;2019:8291624. doi: 10.1155/2019/8291624. eCollection 2019.

3.

CBCT analysis of pharyngeal airway volume and comparison of airway volume among patients with skeletal Class I, Class II, and Class III malocclusion: A retrospective study.

Nath M, Ahmed J, Ongole R, Denny C, Shenoy N.

Cranio. 2019 Aug 12:1-12. doi: 10.1080/08869634.2019.1652993. [Epub ahead of print]

PMID:
31405348
4.

Challenges in Early Diagnosis of Oral Cancer: Cases Series.

Sujir N, Ahmed J, Pai K, Denny C, Shenoy N.

Acta Stomatol Croat. 2019 Jun;53(2):174-180. doi: 10.15644/asc53/2/10.

5.

A Prospective Study of the Clinical and Demographic Profile of Type 2 Diabetes Mellitus Patients Receiving Antidiabetic Drug Combinations.

Gadgade A, Shenoy A, Kamath A, Kamath P, Adhikari P, Rs N, Hadigal S, N S, Shenoy N, Chowta MN.

Curr Diabetes Rev. 2019 Jun 19. doi: 10.2174/1573399815666190619125857. [Epub ahead of print]

PMID:
31250763
6.

Epigenetic dysregulation by aberrant metabolism in renal cell carcinoma can be reversed with Ascorbic acid.

Shenoy N.

Mol Cell Oncol. 2019 Apr 3;6(3):1595309. doi: 10.1080/23723556.2019.1595309. eCollection 2019.

PMID:
31131312
7.

Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma.

Shenoy N, Bhagat TD, Cheville J, Lohse C, Bhattacharyya S, Tischer A, Machha V, Gordon-Mitchell S, Choudhary G, Wong LF, Gross L, Ressigue E, Leibovich B, Boorjian SA, Steidl U, Wu X, Pradhan K, Gartrell B, Agarwal B, Pagliaro L, Suzuki M, Greally JM, Rakheja D, Thompson RH, Susztak K, Witzig T, Zou Y, Verma A.

J Clin Invest. 2019 Mar 4;130:1612-1625. doi: 10.1172/JCI98747. eCollection 2019 Mar 4.

8.

Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly.

Shenoy N, Creagan E, Witzig T, Levine M.

Cancer Cell. 2018 Nov 12;34(5):700-706. doi: 10.1016/j.ccell.2018.07.014. Epub 2018 Aug 30. Review.

9.

Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning?

Shenoy N, Mudireddy M, Vallapureddy R, Leung N, Pagliaro L, Witzig T, Ou FS, Ordog T, Cheville J, Patnaik M, Thompson RH, Tefferi A, Begna K.

Clin Genitourin Cancer. 2018 Dec;16(6):e1117-e1122. doi: 10.1016/j.clgc.2018.06.008. Epub 2018 Jun 28.

PMID:
30077464
10.

Study of S100 Immunostaining in Demonstrating Neural Granulomas in Paucibacillary Leprosy.

Shenoy N, Nair NG.

Indian J Dermatol. 2018 May-Jun;63(3):215-219. doi: 10.4103/ijd.IJD_207_17.

11.

Transurethral incision of ureteroceles in paediatric age group.

Shah H, Tiwari C, Shenoy NS, Dwivedi P, Gandhi S.

Turk J Urol. 2017 Dec;43(4):530-535. doi: 10.5152/tud.2017.57514. Epub 2017 Dec 1.

12.

Re: Targeting Renal Cell Carcinoma with a HIF-2 Antagonist.

Shenoy N, Pagliaro L.

Eur Urol. 2018 Feb;73(2):304-305. doi: 10.1016/j.eururo.2017.10.007. Epub 2017 Nov 2. No abstract available.

PMID:
29102314
13.

RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease.

Jahagirdar R, Attwell S, Marusic S, Bendele A, Shenoy N, McLure KG, Gilham D, Norek K, Hansen HC, Yu R, Tobin J, Wagner GS, Young PR, Wong NCW, Kulikowski E.

Mol Pharmacol. 2017 Dec;92(6):694-706. doi: 10.1124/mol.117.110379. Epub 2017 Sep 29.

PMID:
28974538
14.

Low hypoxia inducible factor-1α (HIF-1α) expression in testicular germ cell tumors - a major reason for enhanced chemosensitivity?

Shenoy N, Dronca R, Quevedo F, Boorjian SA, Cheville J, Costello B, Kohli M, Witzig T, Pagliaro L.

Chin J Cancer Res. 2017 Aug;29(4):374-378. doi: 10.21147/j.issn.1000-9604.2017.04.11.

15.

Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells.

Shenoy N, Bhagat T, Nieves E, Stenson M, Lawson J, Choudhary GS, Habermann T, Nowakowski G, Singh R, Wu X, Verma A, Witzig TE.

Blood Cancer J. 2017 Jul 21;7(7):e587. doi: 10.1038/bcj.2017.65.

16.

Occupation Hazards - Pattern, Awareness and Preventive Measures among Welders from an Unorganized Sector in India.

Joseph N, Venkatesh V, Akash SK, Hegde S, Moras E, Shenoy NP.

J Clin Diagn Res. 2017 May;11(5):LC23-LC28. doi: 10.7860/JCDR/2017/24977.9879. Epub 2017 May 1.

17.

Scleroderma Induced by Pembrolizumab: A Case Series.

Barbosa NS, Wetter DA, Wieland CN, Shenoy NK, Markovic SN, Thanarajasingam U.

Mayo Clin Proc. 2017 Jul;92(7):1158-1163. doi: 10.1016/j.mayocp.2017.03.016. Epub 2017 Jun 7.

PMID:
28599746
18.

Link between dysregulated hypoxia signaling and aberrant methylation in clear cell renal cell carcinoma?

Shenoy N.

Chin J Cancer Res. 2017 Apr;29(2):166-167. doi: 10.21147/j.issn.1000-9604.2017.02.10. No abstract available.

19.

Humming bird sign, a significant sign.

Mittal SH, Rakshith KC, Misri ZK, Pai S, Shenoy N.

Neurol India. 2017 May-Jun;65(3):673-674. doi: 10.4103/neuroindia.NI_45_17. No abstract available.

20.

The effect of angiotensin receptor neprilysin inhibitor, sacubitril/valsartan, on central nervous system amyloid-β concentrations and clearance in the cynomolgus monkey.

Schoenfeld HA, West T, Verghese PB, Holubasch M, Shenoy N, Kagan D, Buono C, Zhou W, DeCristofaro M, Douville J, Goodrich GG, Mansfield K, Saravanan C, Cumin F, Webb RL, Bateman RJ.

Toxicol Appl Pharmacol. 2017 May 15;323:53-65. doi: 10.1016/j.taap.2017.03.014. Epub 2017 Mar 15.

22.

Drugs with anti-oxidant properties can interfere with cell viability measurements by assays that rely on the reducing property of viable cells.

Shenoy N, Stenson M, Lawson J, Abeykoon J, Patnaik M, Wu X, Witzig T.

Lab Invest. 2017 Feb 27. doi: 10.1038/labinvest.2017.18. [Epub ahead of print]

23.

Guillain-Barré syndrome: A rare manifestation of Hansen's disease.

Mittal SH, Rakshith KC, Misri ZK, Pai S, Shenoy N.

Neurol India. 2017 Jan-Feb;65(1):179-180. doi: 10.4103/0028-3886.198191. No abstract available.

24.

Incidence of Opportunistic Infections among HIV-Positive Adults on Highly Active Antiretroviral Therapy in a Teaching Hospital, India: Prospective Study.

Shenoy N, Ramapuram JT, Shenoy A, Ahmed J, Srikant N.

J Int Assoc Provid AIDS Care. 2017 May/Jun;16(3):309-311. doi: 10.1177/2325957416686192. Epub 2017 Jan 4.

PMID:
28050923
25.

Detection of human papilloma virus in potentially malignant and malignant lesions of the oral cavity and a study of associated risk factors.

Bijina BR, Ahmed J, Shenoy N, Ongole R, Shenoy S, Baliga S.

South Asian J Cancer. 2016 Oct-Dec;5(4):179-181. doi: 10.4103/2278-330X.195337.

26.

Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm.

Haddox CL, Shenoy N, Shah KK, Kao JC, Jain S, Halfdanarson TR, Wijdicks EF, Goetz MP.

Ann Oncol. 2017 Mar 1;28(3):673-675. doi: 10.1093/annonc/mdw655. No abstract available.

27.

Simvastatin augments revascularization and reperfusion in a murine model of hind limb ischemia - Multimodal imaging assessment.

Goggi JL, Ng M, Shenoy N, Boominathan R, Cheng P, Sekar S, Bhakoo KK.

Nucl Med Biol. 2017 Mar;46:25-31. doi: 10.1016/j.nucmedbio.2016.11.007. Epub 2016 Nov 17.

PMID:
27984781
28.

Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer.

Bhagat TD, Zou Y, Huang S, Park J, Palmer MB, Hu C, Li W, Shenoy N, Giricz O, Choudhary G, Yu Y, Ko YA, Izquierdo MC, Park AS, Vallumsetla N, Laurence R, Lopez R, Suzuki M, Pullman J, Kaner J, Gartrell B, Hakimi AA, Greally JM, Patel B, Benhadji K, Pradhan K, Verma A, Susztak K.

J Biol Chem. 2017 Jan 20;292(3):837-846. doi: 10.1074/jbc.M116.745208. Epub 2016 Dec 1.

29.

Role of systemic chemotherapy in metastatic hormone-sensitive prostate cancer.

Shenoy N, Kohli M.

Indian J Urol. 2016 Oct-Dec;32(4):257-261. Review.

30.

miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.

Wang Y, Lieberman R, Pan J, Zhang Q, Du M, Zhang P, Nevalainen M, Kohli M, Shenoy NK, Meng H, You M, Wang L.

Mol Cancer. 2016 Nov 10;15(1):70.

31.

Pembrolizumab induced severe sclerodermoid reaction.

Shenoy N, Esplin B, Barbosa N, Wieland C, Thanarajasingam U, Markovic S.

Ann Oncol. 2017 Feb 1;28(2):432-433. doi: 10.1093/annonc/mdw543. No abstract available.

PMID:
27742656
32.

Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective.

Shenoy N, Pagliaro L.

Ann Oncol. 2016 Sep;27(9):1685-95. doi: 10.1093/annonc/mdw241. Epub 2016 Jun 20. Review.

PMID:
27329246
33.

Comparison Between Biofilm Production, Phospholipase and Haemolytic Activity of Different Species of Candida Isolated from Dental Caries Lesions in Children.

Udayalaxmi J, Shenoy N.

J Clin Diagn Res. 2016 Apr;10(4):DC21-3. doi: 10.7860/JCDR/2016/17019.7643. Epub 2016 Apr 1.

34.

Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer.

Xia Y, Huang CC, Dittmar R, Du M, Wang Y, Liu H, Shenoy N, Wang L, Kohli M.

Oncotarget. 2016 Jun 14;7(24):35818-35831. doi: 10.18632/oncotarget.9027.

35.

Hypertrophic olivary degeneration due to the presence of pontine cavernomas.

Mittal SH, Rakshith KC, Misri ZK, Pai S, Shenoy N, Gundabolu G.

Neurol India. 2015 Nov-Dec;63(6):981-3. No abstract available.

36.

Progression of Alport Kidney Disease in Col4a3 Knock Out Mice Is Independent of Sex or Macrophage Depletion by Clodronate Treatment.

Kim M, Piaia A, Shenoy N, Kagan D, Gapp B, Kueng B, Weber D, Dietrich W, Ksiazek I.

PLoS One. 2015 Nov 10;10(11):e0141231. doi: 10.1371/journal.pone.0141231. eCollection 2015.

37.

Role of DNA methylation in renal cell carcinoma.

Shenoy N, Vallumsetla N, Zou Y, Galeas JN, Shrivastava M, Hu C, Susztak K, Verma A.

J Hematol Oncol. 2015 Jul 22;8:88. doi: 10.1186/s13045-015-0180-y. Review.

38.

Corticosteroid-resistant bulbar neurosarcoidosis responsive to intravenous immunoglobulin.

Shenoy N, Tesfaye M, Brown J, Simmons N, Weiss D, Meholli M, Mabie P.

Pract Neurol. 2015 Aug;15(4):289-92. doi: 10.1136/practneurol-2015-001112. Epub 2015 May 2.

PMID:
25935926
39.

Is ADRM1 a Good Target for Cancer Therapy?

Shenoy N.

Acta Haematol. 2015;134(2):86-7. doi: 10.1159/000381658. Epub 2015 Apr 21. No abstract available.

PMID:
25895922
40.

STAQ: A route toward low power, multicolor nanoscopy.

Rosales T, Sackett DL, Xu J, Shi ZD, Xu B, Li H, Kaur G, Frohart E, Shenoy N, Cheal SM, Wu H, Dulcey AE, Hu Y, Li C, Lane K, Griffiths GL, Knutson JR.

Microsc Res Tech. 2015 May;78(5):343-55. doi: 10.1002/jemt.22478. Epub 2015 Mar 12.

PMID:
25762506
41.

Targeting chemokine pathways in esophageal adenocarcinoma.

Shrivastava MS, Hussain Z, Giricz O, Shenoy N, Polineni R, Maitra A, Verma A.

Cell Cycle. 2014;13(21):3320-7. doi: 10.4161/15384101.2014.968426.

42.

Epidermoid cyst of the floor of the mouth.

Baliga M, Shenoy N, Poojary D, Mohan R, Naik R.

Natl J Maxillofac Surg. 2014 Jan;5(1):79-83. doi: 10.4103/0975-5950.140185.

43.

Assessment of learning styles of undergraduate medical students using the VARK questionnaire and the influence of sex and academic performance.

Urval RP, Kamath A, Ullal S, Shenoy AK, Shenoy N, Udupa LA.

Adv Physiol Educ. 2014 Sep;38(3):216-20. doi: 10.1152/advan.00024.2014.

44.

Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome.

Shenoy N, Vallumsetla N, Rachmilewitz E, Verma A, Ginzburg Y.

Blood. 2014 Aug 7;124(6):873-81. doi: 10.1182/blood-2014-03-563221. Epub 2014 Jun 12. Review.

45.

Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.

Hu CY, Mohtat D, Yu Y, Ko YA, Shenoy N, Bhattacharya S, Izquierdo MC, Park AS, Giricz O, Vallumsetla N, Gundabolu K, Ware K, Bhagat TD, Suzuki M, Pullman J, Liu XS, Greally JM, Susztak K, Verma A.

Clin Cancer Res. 2014 Aug 15;20(16):4349-60. doi: 10.1158/1078-0432.CCR-14-0494. Epub 2014 Jun 10.

46.

Oral Cytology for HIV: A New Diagnostic Tool?

Jagad VM, Shenoy N, Ramapuram J, Lewis A, Srikant N, Sarin A.

J Int Assoc Provid AIDS Care. 2015 Jul-Aug;14(4):324-7. doi: 10.1177/2325957414535256. Epub 2014 May 14.

PMID:
24828859
47.

Malignant pleural mesothelioma.

Rishikesh K, Kini U, Shenoy N, Joy B, D'Souza G, Shet A.

J Assoc Physicians India. 2013 Aug;61(8):576-9. No abstract available.

PMID:
24818349
48.

Assessment of quality of life in patients with chronic oral mucosal diseases: a questionnaire-based study.

Rajan B, Ahmed J, Shenoy N, Denny C, Ongole R, Binnal A.

Perm J. 2014 Winter;18(1):e123-7. doi: 10.7812/TPP/13-095.

49.

The perceptual preferences in learning among dental students in clinical subjects.

Shenoy N, Shenoy K A, U P R.

J Clin Diagn Res. 2013 Aug;7(8):1683-5. doi: 10.7860/JCDR/2013/4940.3219. Epub 2013 Aug 1.

50.

Salivary protein markers: a noninvasive protein profile-based method for the early diagnosis of oral premalignancy and malignancy.

Patil A, Choudhari KS, Unnikrishnan VK, Shenoy N, Ongole R, Pai KM, Kartha VB, Chidangil S.

J Biomed Opt. 2013 Oct;18(10):101317. doi: 10.1117/1.JBO.18.10.101317.

Supplemental Content

Loading ...
Support Center